1383 studies found for:    Open Studies | "Breast Diseases"
Show Display Options
Rank Status Study
21 Recruiting SentiMag® Intraoperative Comparison in Breast Cancer
Condition: Breast Cancer
Interventions: Device: SiennaXP;   Drug: Radioisotope;   Drug: Blue dye
22 Unknown  Earlier Breast Cancer Detection Using Automated Whole Breast Ultrasound With Mammography, Including Cost Comparisons
Conditions: Breast Neoplasms;   Ultrasonography
Intervention: Procedure: Comparison of Automated Whole Breast Ultrasound Screening with Blinded Screening Mammography
23 Recruiting Mifepristone and Eribulin in Patients With Metastatic Triple Negative Breast Cancer or Other Specified Solid Tumors
Conditions: Breast Cancer;   Ovarian Epithelial Cancer Recurrent;   Sarcoma;   Non-small Cell Lung Cancer;   Carcinoma, Transitional Cell;   Prostate Cancer;   Prostatic Neoplasms
Intervention: Drug: Mifepristone and Eribulin in combination
24 Recruiting Fulvestrant Combined Anastrozole Versus Anastrozole in Luminal A-like Postmenopausal ABC
Condition: Carcinoma Breast Stage IV
Interventions: Drug: Fulvestrant;   Drug: Anastrozole
25 Not yet recruiting Auricular Acupressure for Chemotherapy-Induced Nausea and Vomiting in Female Breast Cancer Patients
Conditions: Breast Neoplasms;   Nausea;   Vomiting
Interventions: Device: True auricular acupressure (Auricular tape with vaccaria seeds);   Device: Sham auricular acupressure (Auricular tape with Junci Medulla);   Drug: Standard anti-emetic treatment (5-HT3 receptor antagonists and/or Dexamethasone)
26 Not yet recruiting Navigated Early Survivorship Transition in Improving Survivorship Care Planning in Patients With Newly Diagnosed Stage I-III Breast, Lung, Prostate, or Colorectal Cancer and Their Caregivers
Conditions: Cancer Survivor;   Caregiver;   Stage I Colon Cancer;   Stage I Lung Cancer;   Stage I Prostate Cancer;   Stage I Rectal Cancer;   Stage IA Breast Cancer;   Stage IB Breast Cancer;   Stage II Lung Cancer;   Stage IIA Breast Cancer;   Stage IIA Colon Cancer;   Stage IIA Prostate Cancer;   Stage IIA Rectal Cancer;   Stage IIB Breast Cancer;   Stage IIB Colon Cancer;   Stage IIB Prostate Cancer;   Stage IIB Rectal Cancer;   Stage III Lung Cancer;   Stage III Prostate Cancer;   Stage IIIA Breast Cancer;   Stage IIIA Colon Cancer;   Stage IIIA Rectal Cancer;   Stage IIIB Breast Cancer;   Stage IIIB Colon Cancer;   Stage IIIB Rectal Cancer;   Stage IIIC Colon Cancer;   Stage IIIC Rectal Cancer
Interventions: Other: Educational Intervention;   Other: Follow-Up Care;   Procedure: Psychosocial Assessment and Care;   Other: Questionnaire Administration
27 Recruiting Nueva Vida Intervention for Latina Breast Cancer Survivors and Caregivers
Conditions: Quality of Life;   Breast Cancer
Intervention: Behavioral: Nueva Vida Intervention
28 Recruiting CYP2D6 Genotype on the Clinical Effect of Tamoxifen
Conditions: Breast Neoplasms;   Tamoxifen;   Genotype;   CYP2D6
Intervention: Drug: Tamoxifen
29 Recruiting Patient-derived Xenograft (PDX) Modeling of Treatment Response for Triple Negative Breast Cancer
Condition: Triple Negative Breast Cancer
Intervention: Other: Chemotherapy
30 Recruiting Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
Conditions: Ductal Breast Carcinoma In Situ;   Estrogen Receptor and/or Progesterone Receptor Positive;   HER2/Neu Negative;   Invasive Breast Carcinoma;   Multicentric Breast Carcinoma;   Multifocal Breast Carcinoma;   Synchronous Bilateral Breast Carcinoma
Interventions: Drug: Anastrozole;   Drug: Exemestane;   Other: Laboratory Biomarker Analysis;   Drug: Letrozole;   Other: Quality-of-Life Assessment;   Drug: Systemic Chemotherapy;   Drug: Tamoxifen Citrate
31 Recruiting Neuropharmacokinetics of Eribulin Mesylate in Patients With Brain Metastases From Breast, Bladder, or Non-small Cell Lung Cancer
Conditions: Breast Carcinoma Metastatic to the Brain;   Lung Carcinoma Metastatic to the Brain;   Metastatic Malignant Neoplasm to the Adult Brain;   Stage IV Bladder Cancer;   Stage IV Non-Small Cell Lung Cancer
Interventions: Procedure: Therapeutic Conventional Surgery;   Procedure: Biopsy;   Drug: Eribulin Mesylate;   Procedure: Microdialysis;   Other: Pharmacological Study
32 Unknown  Correlation Between Fluorodeoxyglucose (FDG) and FLT Uptake and Gene-Expression Oncotype Assay in Patients With Breast Cancer
Condition: Breast Cancer
33 Unknown  Magnetic Resonance Imaging for the Early Detection of CNS Metastases in Women With Stage IV Breast Cancer
Conditions: Breast Cancer;   Metastatic Cancer
Interventions: Biological: trastuzumab;   Drug: chemotherapy;   Procedure: magnetic resonance imaging
34 Recruiting Cyclophosphamide and Vaccine Therapy With or Without Trastuzumab in Treating Patients With Metastatic Breast Cancer
Condition: Breast Cancer
Interventions: Biological: allogeneic GM-CSF-secreting breast cancer vaccine;   Biological: trastuzumab;   Drug: cyclophosphamide
35 Recruiting A Study of Pertuzumab in Combination With Trastuzumab Plus an Aromatase Inhibitor in Patients With Hormone Receptor-Positive, Metastatic HER2-positive Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Aromatase Inhibitor;   Drug: Induction Chemotherapy;   Drug: pertuzumab;   Drug: trastuzumab
36 Recruiting Investigation of Diagnostic Improvement Gained Through Optimization of MR Methods for Breast Cancer Detection
Condition: Breast Neoplasms
Intervention: Procedure: 3 Tesla Magnetic Resonance Imaging
37 Recruiting Clinical Study of Adjuvant Therapy on Post-menopausal Women With Breast Cancer Under the Guidance of the Results of Preoperative Endocrinotherapy
Condition: Breast Cancer
Interventions: Drug: AI adjuvant therapy;   Drug: AI+chemotherapy adjuvant therapy
38 Recruiting Feasibility Study of Stereotactic Body Radiotherapy for Early Breast Cancer
Condition: Breast Neoplasm
Intervention: Radiation: Stereotactic body radiotherapy (SBRT)
39 Recruiting Influence of Exceptional Patient Characteristics on Everolimus Exposure
Condition: Breast Neoplasms
Intervention: Drug: everolimus dose escalation
40 Recruiting A Phase III Study of BKM120 With Fulvestrant in Patients With HR+,HER2-, AI Treated, Locally Advanced or Metastatic Breast Cancer Who Progressed on or After mTORi
Condition: Metastatic Breast Cancer HR+, HER2-
Interventions: Drug: Fulvestrant;   Drug: BKM120;   Drug: BKM120 matching placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years